STOCK TITAN

Surmodics to Host Virtual Annual Meeting of Shareholders

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Surmodics, a leader in medical device technology, will host its Annual Meeting of Shareholders on February 11 at 4:00 p.m. CT, virtually. CEO Gary Maharaj and Chair Sue Knight will discuss the company's strategic initiatives and business updates. Shareholders can log into the meeting via www.virtualshareholdermeeting.com/SRDX2021 five minutes before it starts. A replay will be available until February 11, 2022. Surmodics specializes in surface modification technologies for medical devices and IVD tests, striving to enhance disease detection and treatment.

Positive
  • None.
Negative
  • None.

Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, will hold its Annual Meeting of Shareholders on Thursday, February 11, at 4:00 p.m. CT (5:00 p.m. ET), as a virtual meeting.

Gary Maharaj, chief executive officer, and Sue Knight, chair of the board, will provide a brief update on business and key strategic initiatives underway at the Company.

To attend the virtual meeting, go to www.virtualshareholdermeeting.com/SRDX2021 at least five minutes prior to the start of the meeting to log in. A webcast replay of the Annual Meeting will be available until February 11, 2022.

About Surmodics, Inc.

Surmodics is the global leader in surface modification technologies for intravascular medical devices and a leading provider of chemical components for in vitro diagnostic (IVD) immunoassay tests and microarrays. Surmodics is pursuing highly differentiated medical devices that are designed to address unmet clinical needs and engineered to the most demanding requirements. This key growth strategy leverages the combination of the Company’s expertise in proprietary surface technologies, along with enhanced device design, development, and manufacturing capabilities. The Company mission remains to improve the detection and treatment of disease. Surmodics is headquartered in Eden Prairie, Minnesota. For more information, visit www.surmodics.com. The content of Surmodics’ website is not part of this press release or part of any filings that the company makes with the SEC.

FAQ

When will Surmodics hold its Annual Meeting of Shareholders?

Surmodics will hold its Annual Meeting of Shareholders on February 11 at 4:00 p.m. CT.

Who will speak at the Surmodics virtual meeting?

CEO Gary Maharaj and Chair Sue Knight will provide updates at the meeting.

How can I attend the Surmodics Annual Meeting?

You can attend the meeting by visiting www.virtualshareholdermeeting.com/SRDX2021 at least five minutes before it starts.

Is there a replay available for the Surmodics Annual Meeting?

Yes, a webcast replay will be available until February 11, 2022.

What does Surmodics specialize in?

Surmodics specializes in surface modification technologies for medical devices and chemical components for in vitro diagnostic tests.

Surmodics, Inc.

NASDAQ:SRDX

SRDX Rankings

SRDX Latest News

SRDX Stock Data

547.28M
14.27M
3.8%
93.73%
2.27%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States of America
EDEN PRAIRIE